secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acer Therapeutics Inc. (—)
CIK:        0001069308
Form:       8-K
Filed at:   2023-06-07T23:59:59+00:00
Accession:  0000950170-23-026809
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Acer Therapeutics faces Nasdaq delisting risk from bid price and MVLS deficiencies
--------------------------------------------------------------------------------

- Received bid price deficiency notice June 5, 2023; must close at $1.00+ for 10 consecutive business days by Dec 4, 2023.
- Received MVLS deficiency notice May 3, 2023; MVLS must be $35M+ for 10 consecutive business days by Oct 30, 2023.
- May also cure MVLS deficiency by meeting minimum stockholders' equity of $2.5 million.
- If not cured by deadlines, eligible for additional 180-day bid price cure period or delisting appeal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069308/000095017023026809/0000950170-23-026809-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069308/000095017023026809/acer-20230605.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-026809

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer